Login / Signup

Implementation of oral anticoagulation treatment guidelines in patients with newly diagnosed atrial fibrillation.

Anat ArbelZomoroda Abu-FulMeir PreisShai CohenWalid Saliba
Published in: British journal of clinical pharmacology (2021)
Despite the increasing OAC treatment rates among high-risk AF patients, mainly attributed to the expanding DOAC use, OAC treatment scope is still far from optimal.
Keyphrases
  • newly diagnosed
  • atrial fibrillation
  • healthcare
  • end stage renal disease
  • heart failure
  • chronic kidney disease
  • ejection fraction
  • coronary artery disease
  • prognostic factors
  • mitral valve